P0251: Inter-rater disagreements in applying the Montreal classification for Crohn’s disease: The Five-Nations Survey StudyECCO'25Year: 2025
Authors: Ukashi, O.(1,2)*;Amiot, A.(3);Laharie, D.(4);Menchén, L.(5,6);Gutierrez, A.(7);Fernandes, S.(8,9);Pessarelli, T.(10);Correia, F.(11);Gonzalez-Muñoza, C.(12,13);López-Cardona, J.(14);Barreiro-de Acosta, M.(15,16);Yanai, H.(2,17);Armuzzi, A.(18,19);Magro, F.(20);Kopylov, U.(1,2);
(1)Sheba Medical Center Tel Hashomer, Gastroenterology Institute, Ramat Gan, Israel;(2)Tel-Aviv University, Faculty of Medical and Health Sciences, Tel-Aviv, Israel;(3)Hopitaux Universitaires Bicêtre- AP-HP- Université Paris Saclay, Department of Gastroenterology, Paris, France;(4)CHU de Bordeaux- Centre Medico-chirurgical Magellan- Hôpital Haut-Lévêque- Université de Bordeaux, Gastroenterology department, Bordeaux, France;(5)Hospital General - Instituto de Investigación Santaria- Gregorio Marañón, Servicio de Aparato Digestivo, Madrid, Spain;(6)Universidad Complutense, Departamento de Medicina, Madrid, Spain;(7)CIBERehd. Hospital General Universitario Dr Balmis of Alicante, Gastroenterology Department, Alicante, Spain;(8)Unidade Local de Saúde Santa Maria, Gastroenterology and Hepatology Department, Lisbon, Portugal;(9)Faculdade de Medicina de Lisboa, Clínica Universitária de Gastrenterologia., Lisbon, Portugal;(10)University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy;(11)Prof. Dr. Fernando Fonseca Hospital, Gastroenterology department, Amadora, Portugal;(12)H. Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(13)Universitat Autònoma de Barcelona, Departament de Medicina, Barcelona, Spain;(14)University Hospital Ramon y Cajal, Gastroenterology and Hepatology department, Madrid, Spain;(15)Hospital Universitario de Santiago de Compostela, Gastroenterology Department, Santiago de Compostela, Spain;(16)FIDIS, Fundacion Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain;(17)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(18)IRCCS Humanitas Research Hospital, IBD Center, Rozzano- Milan, Italy;(19)Humanitas University, Department of Biomedical Sciences, Pieve Emanuele- Milan, Italy;(20)The University of Porto, CINTESIS@RISE- Faculty of Medicine, Porto, Portugal;
P0252: Mild Crohn’s disease is associated with altered sphingolipid metabolism and reduced neutrophilic inflammationECCO'25Year: 2025
Authors: Bourgonje, A.R.(1)*;Ibing, S.(2,3);Argmann, C.(1);Sands, B.E.(1);Dubinsky, M.C.(1);Jacobsen, H.A.(4,5);Larsen, L.(4,5);Jess, T.(4,5);Rajauria, P.(1);Shapiro, J.M.(6);Shah, S.A.(7);Ananthakrishnan, A.N.(8);Suarez-Fariñas, M.(9);Renard, B.Y.(2);Colombel, J.F.(1);Ungaro, R.C.(1);
(1)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;(2)University of Potsdam, Hasso Plattner Institute- Digital Engineering Faculty, Potsdam, Germany;(3)Icahn School of Medicine at Mount Sinai, Hasso Plattner Institute for Digital Health at Mount Sinai, New York, United States;(4)Aalborg University, Center for Molecular Prediction of Inflammatory Bowel Disease- PREDICT- Department of Clinical Medicine- The Faculty of Medicine, Aalborg, Denmark;(5)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;(6)Warren Alpert Medical School of Brown University, Department of Pediatric Gastroenterology, Providence, United States;(7)Warren Alpert Medical School of Brown University, Division of Gastroenterology, Providence, United States;(8)Massachusetts General Hospital and Harvard Medical School, Division of Gastroenterology, Boston, United States;(9)Icahn School of Medicine at Mount Sinai, Center of Biostatistics, New York, United States;
P0253: Identification of baseline Pediatric Crohn’s disease location and complications: How do intestinal ultrasound and magnetic resonance enterography compare?ECCO'25Year: 2025
Authors: Morrissey, M.(1)*;Hudson, A.(1);Huynh, H.Q.(1);Carroll, M.W.(1);Wine, E.(1);Thompson, A.(2);Isaac, D.(1);
(1)University of Alberta, Pediatric Gastroenterology- Hepatology & Nutrition, Edmonton, Canada;(2)University of Alberta, Pediatric Radiology, Edmonton, Canada;
P0254: Cost of telemonitoring with the App TECCU in Inflammatory Bowel Disease compared to standard care in Spain: a multicenter clinical trial of GETECCUECCO'25Year: 2025
Authors: Aguas Peris, M.(1,2);Del Hoyo Francisco, J.(1,2)*;Vicente , R.(3);Barreiro-de Acosta, M.(4);Madero, L.(5,6);Hernández-Camba, A.(7);Melcarne, L.(8);Mesonero, F.(9);Arroyo, M.T.(10);Sicilia, B.(11);Mañosa, M.(12,13);Martín-Arranz, M.D.(14);Pajares, R.(15);Chaparro, M.(16,17);Martínez, P.(18);Chacón, S.(19);Tosca, J.(20);Calvo, M.(21);Marín, S.(22);Sanromán, L.(23);Zabana, Y.(24,25);Sainz, E.(26);Monfort, D.(27);Guerra, I.(28);Varela, P.(29);Baydal, V.(1);Corsino, P.(3);Porto-Silva, S.(4);Gutiérrez, A.(5,6);González, M.(7);Brunet, E.(8);Faubel, R.(30,31);Nos, P.(1,2);
(1)Hospital Universitario y Politécnico La Fe Valencia- ES., Servicio de Gastroenterología, Valencia, Spain;(2)Instituto de Investigación Sanitaria La Fe- Valencia- ES, Servicio de Gastroenterología, Valencia, Spain;(3)Hospital Universitario Miguel Servet- Zaragoza- ES, Servicio de Gastroenterología, Zaragoza, Spain;(4)Hospital Clínico Universitario- Santiago- ES., Servicio de Gastroenterología, Santiago, Spain;(5)Hospital General Universitario Dr. Balmis- ISABIAL- Alicante- ES, Servicio de Gastroenterología, Alicante, Spain;(6)CIBERehd- Instituto de Salud Carlos III- Madrid- ES., Servicio de Gastroenterología, Alicante, Spain;(7)Hospital Universitario Nuestra Señora de la Candelaria- Tenerife- ES, Servicio de Gastroenterología, Tenerife, Spain;(8)Hospital Universitari Parc Taulí- Institut d'Investigació i Innovació Parc Taulí I3PT-CERCA- Sabadell- ES., Servicio de Gastroenterología, Sabadell, Spain;(9)Hospital Universitario Ramón y Cajal- Madrid- ES, Servicio de Gastroenterología, Madrid, Spain;(10)Hospital Universitario Clínico Lozano Blesa- Zaragoza- ES, Servicio de Gastroenterología, Zaragoza, Spain;(11)Hospital Universitario de Burgos- Burgos- ES, Servicio de Gastroenterología, Burgos, Spain;(12)Hospital Universitario Germans Trias i Pujol- Badalona- ES., Servicio de Gastroenterología, Badalona, Spain;(13)CIBERehd- Instituto de Salud Carlos III- Madrid- ES, Servicio de Gastroenterología, Badalona, Spain;(14)Hospital Universitario La Paz- Facultad de Medicina- Universidad Autónoma de Madrid- Instituto de Investigación Sanitaria del Hospital Universitario La Paz IdiPAZ- Madrid- ES, Servicio de Gastroenterología, Madrid, Spain;(15)Hospital Universitario Infanta Sofía- Madrid- ES, Servicio de Gastroenterología, Madrid, Spain;(16)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-Princesa- Universidad Autónoma de Madrid- Madrid- ES, Servicio de Gastroenterología, Madrid, Spain;(17)CIBERehd- Instituto de Salud Carlos III- Madrid- ES, Servicio de Gastroenterología, Madrid, Spain;(18)Hospital Universitario Clínico San Cecilio- Parque Tecnológico de la Salud- Granada- ES, Servicio de Gastroenterología, Granada, Spain;(19)Hospital General Universitario Morales Meseguer- Murcia- ES, Servicio de Gastroenterología, Murcia, Spain;(20)Hospital Universitario Clínico- Valencia- ES, Servicio de Gastroenterología, Valencia, Spain;(21)Hospital Universitario Puerta de Hierro- Madrid- ES, Servicio de Gastroenterología, Madrid, Spain;(22)Hospital Universitario Reina Sofía- Córdoba- ES, Servicio de Gastroenterología, Córdoba, Spain;(23)Hospital Álvaro Cunqueiro- Vigo- ES, Servicio de Gastroenterología, Vigo, Spain;(24)Hospital Universitario Mútua Terrassa- Terrassa- ES, Servicio de Gastroenterología, Terrassa, Spain;(25)CIBERehd- Instituto de Salud Carlos III- Madrid- ES, Servicio de Gastroenterología, Terrassa, Spain;(26)Hospital Universitario Xarxa Asistencial- Manresa- ES, Servicio de Gastroenterología, Manresa, Spain;(27)Consorci Sanitari Terrasa- Barcelona- ES, Servicio de Gastroenterología, Barcelona, Spain;(28)Hospital Universitario de Fuenlabrada- Madrid- ES, Servicio de Gastroenterología, Madrid, Spain;(29)Hospital Universitario de Cabueñes- Gijón- ES, Servicio de Gastroenterología, Gijón, Spain;(30)Unidad Mixta de Investigación en TIC Aplicadas a la Reingeniería de Procesos Sociosanitarios- IIS La Fe-Universitat Politècnica de València- Valencia- ES, Servicio de Gastroenterología, Valencia, Spain;(31)Grupo de Investigación Multidisciplinar en Fisioterapia en Movimiento PTinMOTION- Departamento de Fisioterapia- Universitat de València- Valencia- ES, Servicio de Gastroenterología, Valencia, Spain;
1.Del Hoyo J, Nos P, Bastida G, Faubel R, Muñoz D, Garrido-Marín A, Valero-Pérez E, Bejar-Serrano S, Aguas M. Telemonitoring of Crohn's Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis. J Med Internet Res. 2019 Sep 13;21(9):e15505. doi: 10.2196/15505.
P0255: Predictive potential of microRNA expression for Juvenile Idiopathic Arthritis development in paediatric Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Dorn-Rasmussen, M.(1)*;James, J.P.(2);Malham, M.(3);Burisch, J.(4);Ingels, H.A.S.(5);Riis, L.B.(2);Wewer, V.(1);
(1)Copenhagen University Hospital- Amager and Hvidovre, Department of Paediatric and Adolescence Medicine, Hvidovre, Denmark;(2)Copenhagen University Hospital- Herlev and Gentofte, Department of Pathology, Herlev, Denmark;(3)Royal Hospital for Children and Young People, Department of Paediatric Gastroenterology and Nutrition, Edinburgh, United Kingdom;(4)Copenhagen University Hospital- Amager and Hvidovre, Gastrounit- Medical Division, Hvidovre, Denmark;(5)Copenhagen University Hospital- Rigshospitalet, Department of Paediatrics and Adolescence Medicine, Copenhagen, Denmark;
1. Gordon H, Burisch J, Ellul P, et al. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2024;18(1):1-37. doi:10.1093/ecco-jcc/jjad108
2. Cardile S, Romano C. Current issues in pediatric inflammatory bowel disease-associated arthropathies. World J Gastroenterol. 2014;20(1):45-52. doi:10.3748/wjg.v20.i1.45
3. Alfaifi J, Germain A, Heba AC, et al. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023;29(6):986-999. doi:10.1093/ibd/izac250
4. Attauabi M, Madsen GR, Bendtsen F, et al. Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study. BMJ Open. 2022;12(6). doi:10.1136/bmjopen-2021-055779
P0256: Histologically-proven isolated cuffitis and quality of life among patients with ileoanal pouchECCO'25Year: 2025
Authors: Fischman, M.(1,2)*;Codish, M.(3);Barkan, R.(2,3);White, I.(3,4);Wasserberg, N.(3,4);Rabinowitz, K.(5);Avni-Biron, I.(2);Banai, H.(2);Snir, Y.(2);Yanai, H.(2,3);Dotan, I.(2,3);Ollech, J.(2,3);
(1)Hebrew University of Jerusalem, Department of Military Medicine, Jerusalem, Israel;(2)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(3)Tel Aviv University, Faculty of Medical and Health Sciences, Tel Aviv, Israel;(4)Rabin Medical Center, Division of Surgery, Petah Tikva, Israel;(5)Rabin Medical Center, Felsenstein Medical Research Center, Petah Tikva, Israel;
P0257: Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trialECCO'25Year: 2025
Authors: Pudipeddi, A.(1,2,3)*;Dhanji, P.(1);Paramsothy, S.(1,2);Kariyawasam, V.(1,4);Paramsothy, R.(5);Ghaly, S.(6,7);Haifer, C.(7,8);An, Y.K.(9,10);Begun, J.(9,10);Connor, S.(11,12);Corte, C.(13);Ward, M.(14);De Cruz, P.(15,16);Fung, C.(17);Redmond, D.(1);Chan, W.(18);Mourad, F.(19);Kermeen, M.(1);Leong, R.(1,2,4);
(1)Concord Repatriation General Hospital, Gastroenterology and Liver Services, Sydney, Australia;(2)University of Sydney, Faculty of Medicine and Health, Sydney, Australia;(3)Australian National University, College of Medicine and Health, Sydney, Australia;(4)Macquarie University, Faculty of Medicine and Health Sciences, Sydney, Australia;(5)Ryde Hospital, Department of Gastroenterology, Sydney, Australia;(6)St Vincent's Hospital, Department of Gastroenterology and Hepatology, Sydney, Australia;(7)University of New South Wales, School of Clinical Medicine- St Vincent’s Healthcare Campus, Sydney, Australia;(8)University of New South Wales, Department of Gastroenterology and Hepatology, Sydney, Australia;(9)Mater Hospital, Department of Gastroenterology, Brisbane, Australia;(10)University of Queensland, Mater Research Institute, Brisbane, Australia;(11)Liverpool Hospital, Department of Gastroenterology, Sydney, Australia;(12)University of New South Wales, South West Sydney Clinical Campuses- UNSW Medicine & Health, Sydney, Australia;(13)Royal Prince Alfred Hospital, AW Morrow Gastroenterology Centre, Sydney, Australia;(14)The Alfred Hospital, Department of Gastroenterology, Melbourne, Australia;(15)Austin Hospital, Department of Gastroenterology, Melbourne, Australia;(16)University of Melbourne, Department of Medicine- Austin Academic Centre, Melbourne, Australia;(17)Concord Repatriation General Hospital, Department of Anatomical Pathology, Sydney, Australia;(18)Singapore General Hospital, Department of Gastroenterology, Singapore City, Singapore;(19)American University of Beirut, Department of Gastroenterology, Beirut, Lebanon;
P0258: APOA1, a promising biomarker for early monitoring recurrence of ulcerative colitis.ECCO'25Year: 2025
Authors: Meng, Q.(1)*;Ding, S.(1);
(1)Peking University Third Hospital, Department of Gastroenterology, Beijing, China;
1Gros B, Kaplan GG. Ulcerative Colitis in Adults: A Review. Jama. 2023;330(10):951-965.
2 Chang JT. Pathophysiology of Inflammatory Bowel Diseases. N Engl J Med. 2020;383(27):2652-2664.
3 Xu D, Ma R, Ju Y, et al. Cholesterol sulfate alleviates ulcerative colitis by promoting cholesterol biosynthesis in colonic epithelial cells. Nat Commun. 2022;13(1):4428.
4 Vich Vila A, Hu S, Andreu-Sánchez S, et al. Faecal metabolome and its determinants in inflammatory bowel disease. Gut. 2023;72(8):1472-1485.
5 Sinha SR, Haileselassie Y, Nguyen LP, et al. Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation. Cell Host Microbe. 2020;27(4):659-670.e655.
6 Song X, Sun X, Oh SF, et al. Microbial bile acid metabolites modulate gut RORγ(+) regulatory T cell homeostasis. Nature. 2020;577(7790):410-415.
7 Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583.
8 Tews HC, Schmelter F, Kandulski A, et al. Unique Metabolomic and Lipidomic Profile in Serum From Patients With Crohn's Disease and Ulcerative Colitis Compared With Healthy Control Individuals. Inflamm Bowel Dis. 2023.
P0259: Iron deficiency anemia patterns and outcomes in Romanian inflammatory bowel disease patients: results of a prospective cohort studyECCO'25Year: 2025
Authors: State, R.M.(1,2)*;Marinica, A.(1);Mateescu, R.B.(1,2);
(1)Colentina Clinical Hospital, Gastroenterology, Bucharest, Romania;(2)University of Medicine and Pharmacy Carol Davila, Gastroenterology, Bucharest, Romania;
[1] Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211-222. doi:10.1093/ecco-jcc/jju009
P0260: Scoring indices grading radiologic disease activity severity on magnetic resonance imaging strongly reflect clinical healing of Crohn’s perianal fistulasECCO'25Year: 2025
Authors: De Gregorio, M.(1,2)*;Winata, L.S.(2,3);Behrenbruch, C.C.(2,4);Hartley, I.(1,2);Connor, S.J.(5,6);D'Souza, B.(2,7);Johnston, M.J.(4);Kamm, M.A.(1,2);Keck, J.O.(4);Rimola, J.(8);Sutherland, T.(2,3);Woods, R.J.(4);Wright, E.K.(1,2);Connell, W.R.(1);Thompson, A.J.(1);Ding, N.S.(1,2);
(1)St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Australia;(2)University of Melbourne, Medicine, Parkville, Australia;(3)St Vincent's Hospital Melbourne, Medical Imaging, Fitzroy, Australia;(4)St Vincent's Hospital Melbourne, Colorectal Surgery, Fitzroy, Australia;(5)Liverpool Hospital Sydney, Gastroenterology, Sydney, Australia;(6)UNSW Sydney- South West Sydney Clinical Campuses, UNSW Medicine and Health, Sydney, Australia;(7)Northern Hospital, Colorectal Surgery, Epping, Australia;(8)Hospital Clínic Barcelona, Radiology, Barcelona, Spain;
P0261: The hidden impact of surgery for inflammatory bowel disease: a qualitative exploration of sexual function and intimacyECCO'25Year: 2025
Authors: Joshi, S.(1)*;Pelly, T.(1);Alrubaiy, L.(2);Dames, N.(3);Dibley, L.(4);Fourie, S.(5);Rajeswaran, K.(6);White, I.(7);Hart, A.(1);Tozer, P.(1);
(1)St Mark's Academic Institute, Robin Phillips' Fistula Research Unit, London, United Kingdom;(2)St Mark's Academic Institute, Gastroenterology, London, United Kingdom;(3)St Mark's Academic Institute, Patient Representative, London, United Kingdom;(4)University of Greenwich, School of Health Sciences, London, United Kingdom;(5)University of Oxford, Radcliffe Department of Medicine, Oxford, United Kingdom;(6)Babylon Health, General Practice and Psychosexual Therapy, London, United Kingdom;(7)Royal Marsden NHS Foundation Trust, Psychosexual Therapy, London, United Kingdom; Sex-PROM
P0262: Analysis of remission maintenance rate according to the extent of MES 1 inflammation in ulcerative colitisECCO'25Year: 2025
Authors: Kanazawa, M.(1)*;Tominaga, K.(1);Tanaka, T.(1);Kojimahara, S.(1);Masuyama, S.(1);Watanabe, S.(1);Sugaya, T.(1);Haruyama, Y.(2);Irisawa, A.(1);
(1)Dokkyo Medical University School of Medicine, Gastroenterology, Tochigi, Japan;(2)Dokkyo Medical University School of Medicine, Integrated Research Faculty for Advanced Medical Sciences, Tochigi, Japan;
P0263: Comparative analysis of the faecal biomarker potential of Plasminogen activator inhibitor type 1 (PAI-1) to the Calprotectin in Inflammatory Bowel DiseasesECCO'25Year: 2025
Authors: Jójárt, B.(1,2,3)*;Resál, T.(1);Bacsur, P.(1,4);Farkas, B.(1);Ivány, E.(1);Kajári, L.(1,3);Szabó, V.(1,2,3);Kata, D.(5);Földesi, I.(5);Pallagi, P.(1,2,3);Molnár, T.(1);Maléth, J.(1,2,3);Farkas, K.(1,4);
(1)University of Szeged, Szent-Györgyi Albert Medical School- Department of Medicine, Szeged, Hungary;(2)HCEMM-USz, Molecular Gastroenterology Research Group, Szeged, Hungary;(3)University of Szeged, ELKH-USZ Momentum Epithelial Cell Signaling and Secretion Research Group, Szeged, Hungary;(4)HCEMM-USz, Translational Colorectal Research Group, Szeged, Hungary;(5)University of Szeged, Szent-Györgyi Albert Medical School- Institute of Laboratory Medicine, Szeged, Hungary; Epithelial Cell Signaling and Secretion Research Group
1. Jójárt B, Resál T, Kata D, Molnár T, Bacsur P, Szabó V, Varga Á, Szántó KJ, Pallagi P, Földesi I, Molnár T, Maléth J, Farkas K. Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases. J Crohns Colitis. 2024 Mar 1;18(3):392-405. doi: 10.1093/ecco-jcc/jjad160. PMID: 37751311; PMCID: PMC10906952.
P0264: Using a machine learning model to grade clip-level endoscopic inflammation reveals the heterogeneity of mucosal inflammation in ulcerative colitisECCO'25Year: 2025
Authors: George, A.(1);Gottlieb, K.(2);Baxi, S.(3);Eastman, W.(2);Colucci, D.(3);Battioui, C.(2);Wang, Y.(3);Lehrer, J.(4);Brodskiy, P.(4);Haft-Javaherian, M.(4);Rubin, D.T.(1)*;
(1)The University of Chicago Medicine Inflammatory Bowel Disease Center, Section of Gastroenterology- Hepatology- and Nutrition, Chicago, United States;(2)Eli Lilly & Company, Clinical Research, Indianapolis, United States;(3)Iterative Health Inc., Data & Insights, Cambridge, United States;(4)Iterative Health Inc., Machine Learning, Cambridge, United States;
Food and Drug Administration. Ulcerative Colitis: Developing Drugs for Treatment [Internet]. 2022 [cited 2024 Oct 17]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/ulcerative-colitis-developing-drugs-treatment
Hashash, J. G., Yu Ci Ng, F., Farraye, F. A., Wang, Y., Colucci, D. R., Baxi, S., . . . & Melmed, G. Y. (2024). Inter-and intraobserver variability on endoscopic scoring systems in crohn’s disease and ulcerative colitis: A systematic review and meta-analysis. Inflammatory Bowel Diseases, izae051.
Vuyyuru, S. K., Ma, C., Nguyen, T. M., Zou, G., Peyrin-Biroulet, L., Danese, S., . . . & Jairath, V. (2024). Differential efficacy of medical therapies for ulcerative colitis according to disease extent: Patient-level analysis from multiple randomized controlled trials. EClinicalMedicine, 72.
Rubin, D. T., Gottlieb, K., Colombel, J. F., Schott, J. P., Erisson, L., Prucka, B., . . . & McGill, J. (2023). Development of a novel ulcerative colitis endoscopic mayo score prediction model using machine learning. Gastro Hep Advances, 2(7), 935-942.
P0265: A retrospective cohort study of pregnant women with Inflammatory Bowel Disease – outcomes from a multidisciplinary clinic in a tertiary centreECCO'25Year: 2025
Authors: Yeo, J.H.(1)*;Mackenzie, H.(1);Lambo, D.(2);Parker, H.(1);McCartney, S.(1);Williams, D.(2);Harrow, P.(1);
(1)University College London Hospital, Gastroenterology, London, United Kingdom;(2)University College London Hospital, Obstetric Medicine, London, United Kingdom;
- Eades CE, Cameron DM, Evans JMM. Prevalence of gestational diabetes mellitus in Europe: A meta-analysis. Diabetes Res Clin Pract. 2017 Jul;129:173-181. doi: 10.1016/j.diabres.2017.03.030. Epub 2017 May 9. PMID: 28531829.
P0266: Ultrasound Spectroscopy for the detection of inflammation in inflammatory bowel diseaseECCO'25Year: 2025
Authors: Petzsche, J.(1)*;Chaghaneh, O.(1);Kegel, J.(1);Koop, P.H.(1);Gabriel, T.(1);Pfeifer, J.(1);Kampfrath, N.(2);Queck, A.(2);Arsova, M.(2);Büttner, M.(2);Nauber, R.(3);Fettweis, G.(3);Siegmund, B.(4);Hampe, J.(1);Lehmann, M.(4);Herzog, M.(1);
(1)TU Dresden Faculty of Medicine Carl Gustav Carus, Else Kröner Fresenius Center for Digital Health, Dresden, Germany;(2)TU Dresden Faculty of Medicine Carl Gustav Carus, Medical Department 1- University Hospital Dresden, Dresden, Germany;(3)TU Dresden Faculty of Electrical Engineering and Information Technology, Vodafone Chair for Mobile Communications, Dresden, Germany;(4)Humboldt-Universität zu Berlin- Campus Benjamin Franklin, Department of Gastroenterology- Infectious Diseases and Rheumatology- Charité - Universitätsmedizin Berlin- corporate member of Freie Universität Berlin, Berlin, Germany; HybridEcho
P0267: Proactive Remote Monitoring of Inflammatory Bowel Disease for Improved Outcomes and Flare PredictionECCO'25Year: 2025
Authors: Goren, M.(1,2,3)*;Talan Asher, A.(1,2,4);Haj, O.(1,2);Godis, T.(3);Briskman Shakhnovsky, N.(4);Levi, T.(3);Fizdel, B.(3);Shtein, I.(4);Galper, A.(3);Albshesh, A.(1,2);Barda, L.(1,2);Ben Shalom, Y.(1,2);Laks, D.(1,2);Tzur, M.(1,2);Ungar, B.(1,2);Sagi, M.(4);Sina, S.(4);Goshen, G.(4);Ben-Horin, S.(1,2);Zimlichman, E.(3,4);Kopylov, U.(1,2);
(1)Sheba Medical Center, Gastroenterology Department, Ramat Gan, Israel;(2)Tel Aviv University, Faculty of Medical and Health Sciences, Tel Aviv, Israel;(3)Sheba Medical Center, Sheba Beyond- Virtual Hospital, Ramat Gan, Israel;(4)Sheba Medical Center, Sheba ARC- The Center for Digital Innovation, Ramat Gan, Israel;
P0268: Patient-reported outcomes in a Greek cross-sectional survey of inflammatory bowel disease patients treated with biologic therapyECCO'25Year: 2025
Authors: Tzanetakos, C.(1);Vakouftsi, V.(2)*;Mavridoglou, G.(3);Gourzoulidis, G.(1);
(1)Health Through Evidence Consulting G.P., HTA and Real-World Evidence, Athens, Greece;(2)Hellenic Society of Crohn’s disease’s and Ulcerative Colitis’ patients HELLESCC, President, Athens, Greece;(3)University of Peloponnese, Business and Organizations Administration, Kalamata, Greece;
P0269: Examination of the safety and effectiveness of budesonide rectal foam for patients with Ulcerative Colitis: Final report of post-marketing surveillance in JapanECCO'25Year: 2025
Authors: Omori, T.(1)*;Saruta, M.(2);Nagaki, A.(3);Kuramoto, K.(4);Suzuki, Y.(5);
(1)Kyorin University School of Medicine-Suginami Hospital, Department of Gastroenterology and Hepatology, Tokyo, Japan;(2)The Jikei University School of Medicine, Department of Internal Medicine-Division of Gastroenterology and Hepatology, Tokyo, Japan;(3)EA Pharma Co.-Ltd., Medical Department, Tokyo, Japan;(4)Kissei Pharmaceutical Co.-Ltd., Pharmacovigilance & Post-Marketing Surveillance, Tokyo, Japan;(5)Ginza Central Clinic, Department of Internal Medicine, Tokyo, Japan;
P0270: Standardisation of Rapid TDM Assay with WHO International Reference Material for Anti-Infliximab AntibodiesECCO'25Year: 2025
Authors: Dähn, O.(1)*;Johnson, J.(1);Ricken, B.(1);Anchling, L.(2);Gerhold, C.B.(3);
(1)BÜHLMANN Laboratories AG, POC & ST Development, Schönenbuch, Switzerland;(2)BÜHLMANN Laboratories AG, Global Marketing, Schönenbuch, Switzerland;(3)BÜHLMANN Laboratories AG, Development, Schönenbuch, Switzerland;